New Tactics for Bladder Cancer After decades without treatment advances, options for patients with bladder cancer are now more numerous. by Kendall K. Morgan Survivor Profile Hope and Endurance Bladder cancer survivor Randy Layne and his wife, Ellen, faced his diagnosis, treatment and recovery together. by Martha Irvine Yesterday & Today Who Loves Ya, Baby? Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference. by Jocelyn Selim Cancer Talk Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky More Posts